| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0163-7258(98)00020-5 |
| P698 | PubMed publication ID | 9804053 |
| P2093 | author name string | Ghivizzani SC | |
| Robbins PD | |||
| P2860 | cites work | Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy | Q45883146 |
| Problems and potential for gene therapy in Duchenne muscular dystrophy | Q45883156 | ||
| Selection and use of ligands for receptor-mediated gene delivery to myogenic cells | Q45883352 | ||
| Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12. | Q45883488 | ||
| A two-component expression system that responds to inflammatory stimuli in vivo | Q45883791 | ||
| Eradication of tumor growth via biolistic transformation with allogeneic MHC genes. | Q45883822 | ||
| A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor. | Q52286697 | ||
| Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype | Q64382611 | ||
| Observations of the carrier state in hamsters infected with Leptospira interrogans serotype pomona | Q70476166 | ||
| Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis | Q71503443 | ||
| Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 | ||
| Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors | Q24683259 | ||
| In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
| Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells | Q34073981 | ||
| A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice | Q34135412 | ||
| DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors | Q34251868 | ||
| Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity | Q34334817 | ||
| A humanized system for pharmacologic control of gene expression | Q34394730 | ||
| An adenovirus mutant that replicates selectively in p53-deficient human tumor cells | Q34399844 | ||
| Overexpression of the herpes simplex virus type 1 immediate-early regulatory protein, ICP27, is responsible for the aberrant localization of ICP0 and mutant forms of ICP4 in ICP4 mutant virus-infected cells | Q35866195 | ||
| Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies | Q35870207 | ||
| Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. | Q35870225 | ||
| Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. | Q35871002 | ||
| A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal | Q35915922 | ||
| Human gene therapy comes of age. | Q36220668 | ||
| A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells | Q36366136 | ||
| New cationic lipid formulations for gene transfer | Q36841020 | ||
| Replication-defective herpes simplex virus vectors for gene transfer in vivo | Q37248260 | ||
| Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector | Q37251114 | ||
| A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase | Q37551841 | ||
| Transfer of genes to humans: early lessons and obstacles to success | Q40418899 | ||
| Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis | Q40624060 | ||
| Adeno-associated virus: integration at a specific chromosomal locus | Q40852243 | ||
| The fate of individual myoblasts after transplantation into muscles of DMD patients | Q40883106 | ||
| The basic science of gene therapy | Q40907463 | ||
| Second-generation adenovirus vectors | Q40939190 | ||
| Applications of gene therapy to the CNS. | Q40957115 | ||
| Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator | Q41111341 | ||
| A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease | Q41192401 | ||
| Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis | Q41226051 | ||
| Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials. | Q41261328 | ||
| Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants | Q41263288 | ||
| Replicating viruses as selective cancer therapeutics | Q41335851 | ||
| Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors | Q41575041 | ||
| Use of retroviral vectors for gene transfer and expression | Q41582824 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. | Q42483331 | ||
| Engineering herpes simplex virus vectors for gene transfer to neurons | Q45764432 | ||
| Recombinant adeno-associated virus for muscle directed gene therapy | Q45764433 | ||
| AAV as a viral vector for human gene therapy. Generation of recombinant virus | Q45788079 | ||
| Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial | Q45866236 | ||
| Methods for construction of adenovirus vectors | Q45866700 | ||
| P433 | issue | 1 | |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 35-47 | |
| P577 | publication date | 1998-10-01 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | Viral vectors for gene therapy | |
| P478 | volume | 80 |
| Q34994534 | "Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair |
| Q34779805 | A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy |
| Q38961417 | A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice |
| Q40579830 | A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging |
| Q38220813 | A sight on the current nanoparticle-based gene delivery vectors |
| Q43196877 | Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures |
| Q45235890 | Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone |
| Q40041714 | An efficient, non-viral dendritic vector for gene delivery in tissue engineering. |
| Q30430108 | Analysis of in vitro transfection by sonoporation using cationic and neutral microbubbles |
| Q40154012 | Anti-CD25 targeted killing of bicistronically transduced cells: a novel safety mechanism against retroviral genotoxicity |
| Q93353440 | Antiangiogenic Gene Therapy in Cancer |
| Q40700675 | Antiinflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches |
| Q40891208 | Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo |
| Q45876516 | Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system |
| Q24792845 | Beta-Adrenergic gene therapy for cardiovascular disease |
| Q38499923 | Biologic response of human intervertebral disc cells to gene therapy cocktail. |
| Q34444274 | Biological mechanisms of glioma invasion and potential therapeutic targets |
| Q36439944 | Bioplasty for vertebral fractures: preliminary results of a pre-clinical study on goats using autologous modified skin fibroblasts |
| Q35763388 | Biotinylated dextran amine as a marker for fetal hypothalamic homografts and their efferents. |
| Q33294626 | Cell loss during pseudoislet formation hampers profound improvements in islet lentiviral transduction efficacy for transplantation purposes |
| Q36057444 | Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1 |
| Q40039573 | Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation |
| Q51596505 | Complexation of retroviruses with charged polymers enhances gene transfer by increasing the rate that viruses are delivered to cells. |
| Q40234083 | Construction and expression of human PTEN tumor suppressor gene recombinant adenovirus vector |
| Q35594134 | Current status of gene delivery and gene therapy in lacrimal gland using viral vectors. |
| Q37677605 | Delivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences |
| Q37247948 | Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunity |
| Q34098346 | Delivery of therapeutic molecules into the CNS. |
| Q42326959 | Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells |
| Q45874476 | Direct gene delivery strategies for the treatment of rheumatoid arthritis |
| Q41197665 | Diseases originate and terminate by genes: unraveling nonviral gene delivery |
| Q42828085 | Effect of neurotrophin-3 genetically modified olfactory ensheathing cells transplantation on spinal cord injury |
| Q50738650 | Effects of small interfering RNA targeting sphingosine kinase-1 gene on the animal model of Alzheimer's disease. |
| Q92635178 | Emerging Concepts and Challenges in Rheumatoid Arthritis Gene Therapy |
| Q34452558 | Engineered external guide sequences effectively block viral gene expression and replication in cultured cells |
| Q40619697 | Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo |
| Q38378499 | Engineering Stem Cells for Biomedical Applications. |
| Q38038565 | Enhancing human nucleus pulposus cells for biological treatment approaches of degenerative intervertebral disc diseases: a systematic review |
| Q33916410 | Episomal vectors for gene expression in mammalian cells |
| Q33799990 | Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery. |
| Q40024210 | Ex vivo magnetofection with magnetic nanoparticles: a novel platform for nonviral tissue engineering. |
| Q40554363 | Gene and stem cell therapy: alone or in combination? |
| Q34981906 | Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction. |
| Q34070348 | Gene therapy for autoimmune disorders |
| Q37260599 | Gene therapy for cancer through adenovirus vector‑mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting |
| Q35629564 | Gene therapy for degenerative disc disease |
| Q77786312 | Gene therapy for rheumatoid arthritis |
| Q34140992 | Gene therapy for rheumatoid arthritis |
| Q34526913 | Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators |
| Q35630146 | Gene therapy in orthopaedic surgery: the current status |
| Q45869418 | Gene therapy. Therapeutic approaches and implications |
| Q33892816 | Gene transfer to suppress bone marrow alkylation sensitivity. |
| Q34492788 | Genetic targeting of the renin-angiotensin system for long-term control of hypertension |
| Q38401529 | HIF1A overexpression using cell-penetrating DNA-binding protein induces angiogenesis in vitro and in vivo. |
| Q44698738 | HSV-1 helper virus 5dl1.2 suppresses sodium currents in amplicon-transduced neurons |
| Q34229310 | Haemophilias: advances towards genetic engineering replacement therapy |
| Q35544053 | Hepatic Insulin Gene Therapy in Insulin-Dependent Diabetes Mellitus |
| Q49697673 | Human β-defensin-2 gene transduction of dental pulp cells: A model for pulp antimicrobial gene therapy |
| Q35836406 | Identification and characterization of human nucleus pulposus cell specific serotypes of adeno-associated virus for gene therapeutic approaches of intervertebral disc disorders |
| Q45872456 | In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery |
| Q40697607 | In vivo new bone formation by direct transfer of adenoviral-mediated bone morphogenetic protein-4 gene. |
| Q40639503 | Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells |
| Q30440247 | Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach |
| Q38383483 | Inorganic nanovectors for nucleic acid delivery |
| Q90398077 | Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model |
| Q45882377 | Introduction to the background, principles, and state of the art in suicide gene therapy. |
| Q37265519 | Large animal models of neurological disorders for gene therapy |
| Q43703247 | Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells |
| Q34418987 | Local gene delivery to the vessel wall |
| Q38366410 | Magnetic nanoparticles: Applications in gene delivery and gene therapy. |
| Q50436799 | Manipulation of single-stranded DNA by using an artificial site-selective DNA cutter composed of cerium(IV)/EDTA and phosphonate-oligonucleotide conjugates |
| Q45867483 | Molecular biology and neurosurgery in the third millennium |
| Q45861474 | Molecular switches for regulating therapeutic genes |
| Q45392043 | Moloney murine leukemia virus decay mediated by retroviral reverse transcriptase degradation of genomic RNA. |
| Q37004107 | Nanoparticulate systems for polynucleotide delivery. |
| Q33991706 | New approaches for imaging in gene therapy. |
| Q36390509 | New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. |
| Q45863480 | Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy |
| Q39037975 | Optimizing A Lipocomplex-Based Gene Transfer Method into HeLa Cell Line |
| Q34602827 | Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice |
| Q81757717 | Orthopaedic applications of gene therapy |
| Q39100805 | PEGylated and non-PEGylated siRNA lipoplexes formulated with cholesteryl cytofectins promote efficient luciferase knockdown in HeLa tat luc cells. |
| Q40808305 | Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration |
| Q39941142 | Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct. |
| Q58875433 | Post-modification of poly(glycidyl methacrylate)s with alkyl amine and isothiocyanate for effective pDNA delivery |
| Q55341740 | Preclinical methods for the evaluation of periodontal regeneration in vivo. |
| Q51093890 | Quantitative relations of acoustic inertial cavitation with sonoporation and cell viability. |
| Q37774587 | Quantum dot-based theranostics |
| Q33733922 | Quaternary complexes composed of plasmid DNA/protamine/fish sperm DNA/stearic acid grafted chitosan oligosaccharide micelles for gene delivery |
| Q42272671 | RNA interference with special reference to combating viruses of crustacea |
| Q45864075 | Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochromeP450 21-hydroxylase into the adrenal gland of21-hydroxylase-deficient mice |
| Q33842038 | Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells |
| Q35978875 | Spermine-modified Antheraea pernyi silk fibroin as a gene delivery carrier |
| Q33815320 | Strategies for molecular intervention in esophageal cancers and their precursor lesions |
| Q50049555 | Sweet Vector for Gene Delivery: the Sugar Decoration of Polyplexes Reduces Cytotoxicity with a Balanced Effect on Gene Expression |
| Q45193147 | Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes |
| Q50921323 | Synthesis and Assembly of Click-Nucleic-Acid-Containing PEG-PLGA Nanoparticles for DNA Delivery. |
| Q45880477 | Systemic delivery of IL-10 by an AAV vector prevents vascular remodeling and end-organ damage in stroke-prone spontaneously hypertensive rat. |
| Q59353538 | THE JEREMIAH METZGER LECTURE NOVEL THERAPEUTIC STRATEGIES OF ALLERGIC AND IMMUNOLOGIC DISORDERS |
| Q35630559 | Targeted molecular imaging |
| Q42556528 | Telomerase Activity in Articular Chondrocytes Is Lost after Puberty |
| Q45877691 | TerplexDNA gene carrier system targeting artery wall cells |
| Q91554818 | The Impact of Alkyl-Chain Purity on Lipid-Based Nucleic Acid Delivery Systems - Is the Utilization of Lipid Components with Technical Grade Justified? |
| Q37439475 | The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective. |
| Q33851136 | The potential role of gene therapy in the treatment of bladder cancer |
| Q49064735 | The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy |
| Q36768805 | Theranostic agents for intracellular gene delivery with spatiotemporal imaging |
| Q34079558 | Transcriptional control: an essential component of cancer gene therapy strategies? |
| Q37332895 | Transduction of Schistosoma japonicum schistosomules with vesicular stomatitis virus glycoprotein pseudotyped murine leukemia retrovirus and expression of reporter human telomerase reverse transcriptase in the transgenic schistosomes |
| Q45874883 | Transplantation of virally transduced cells into the dermis of immunocompetent and immunodeficient (SCID) mice to determine gene expression profile and differential donor cell survival |
| Q38510992 | Transporter molecules influence the gene expression in HeLa cells |
| Q34277509 | Treatment of osteochondral injuries. Genetic engineering |
| Q103825405 | Ultrasound Microbubble-Mediated VHL Regulates the Biological Behavior of Ovarian Cancer Cells |
| Q39614132 | Ultrasound-mediated gene transfection in vitro: effect of ultrasonic parameters on efficiency and cell viability |
| Q35599603 | Use of gene therapy in central nervous system repair |
| Q46160383 | Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells |
| Q34592330 | Using nuclear targeting signals to enhance non-viral gene transfer |
| Q40732042 | Viral gene delivery |
| Q79768923 | [Role of gene therapy in trauma and orthopedic surgery] |
| Q74101103 | [Treatment of type 1 Gaucher's disease. Still a long way to go] |
| Q92642815 | p21 in Cancer Research |
Search more.